Document:

Exhibit
10.1

 

AGREEMENT
AND PLAN OF MERGER

 

THIS
AGREEMENT AND PLAN OF MERGER (the “Agreement”) is made as of February 5, 2020 (the “Effective
Date”), by and between HealthLynked Corp., a Nevada corporation (the “Parent”), HLYK Florida, LLC,
a Florida limited liability company (the “Company”), Cura Health Management LLC, a Florida limited liability
company (the “Target”), ACO Health Partners, LLC, a Delaware limited liability company (“AHP”),
and Bradberry Holdings LLC and FocusOne Holdings, LLC, each in their capacity (each, a “Seller” and, collectively,
the “Sellers”).

 

RECITALS

 

WHEREAS,
Parent is a public company quoted on the OTC:QB; 

 

WHEREAS, Company is a wholly owned subsidiary of Parent; 

 

WHEREAS,
AHP is a wholly owned subsidiary of Target;

 

WHEREAS,
Sellers are the owners of all of the issued and outstanding membership interests of Target (the “Interests”);

 

WHEREAS,
the parties intend to effect a merger of Target with and into Company (the “Merger”) in accordance with this
Agreement, and Florida law.

 

WHEREAS,
upon consummation of the Merger, Target will cease to exist and Company will continue as the surviving entity and as a wholly
owned subsidiary of Parent; and

 

WHEREAS,
the parties desire to make certain representations, warranties, covenants and agreements in connection with the Merger, and also
to prescribe various conditions to the Merger, as set forth in, and subject to the provisions of, this Agreement.

 

AGREEMENT

 

NOW
THEREFORE, in consideration of the terms and conditions contained herein, intending to be legally bound, the parties agree
as follows:

 

	 	1.	Recitals.
    The recitals to this Agreement, which the parties acknowledge are true and correct, are incorporated into this Agreement by
    this reference.

 

	 	2.	Effective
    Time of Merger. Subject to the terms and conditions of this Agreement, upon the satisfaction or waiver of the closing
    conditions set forth in Section 6.2, the parties shall file Articles of Merger (the “Articles”) with the
    Florida Department of State Division of Corporations (the “Secretary”) in such form as required under Florida
    law. The Merger shall become effective upon the acceptance for filing of the Articles by the Secretary or at such later time
    as agreed to by the parties and specified in the Articles (the “Effective Time”).

 

     

     

    

 

	3.	Effect
    of the Merger.

 

		3.1.	At
the Effective Time, the effect of the Merger will be as provided in the applicable provisions of Florida law, this Agreement,
and the Articles. Without limiting the generality of the foregoing, and subject to such applicable provisions, at the Effective
Time:

 

		3.1.1.	the
separate existence of Target will cease;

		 	 

		3.1.2.	Target
will be merged with and into Company;

		 	 

		3.1.3.	all
Interests will be cancelled and will cease to exist;

		 	 

		3.1.4.	Company
will continue as the surviving entity;

		 	 

		3.1.5.	Company
shall be obligated to pay the Consideration, as defined below, in accordance with this Agreement;

		 	 

		3.1.6.	all
of the property, rights, privileges, and powers of Target will vest in Company; and

		 	 

		3.1.7.	all
duties and obligations of Target will become the duties and obligations of Company.

		 	 

		3.2.	The
parties intend that the transactions set forth in this Agreement be treated as a “reorganization” within the meaning
of Sections 368(a)(1)(A) of the Internal Revenue Code of 1986, as amended (”Code”), and as required thereunder,
this Agreement be treated as a “plan of reorganization” within the meaning of Section 368 of the Code and the Treasury
Regulations promulgated thereunder.

 

		4.	Organizational
Documents. At the Effective Time, the organizational documents of Target will terminate and the organizational documents of
Company shall continue in full force and effect, as may be amended in the future from time to time.

		 	 

		5.	Merger
Consideration. The aggregate merger consideration (the “Consideration”) payable to Sellers as owners of
the Interests shall be as follows:

 

		5.1.	$437,500
payable half each to the Sellers at the Closing, as defined below, subject to adjustment in accordance with Sections 5.4 and 10.9
(the “Initial Payment”);

		 	 

		5.2.	Common
shares of Parent with an aggregate value of $875,000 half each to the Sellers based on the average volume weighted average price
(“VWAP”) of the five (5) business days prior to Closing, which shall be issued to the Sellers at the Closing;

 

    Page 2

     

    

 

		5.3.	Earn-out
payments in an aggregate amount of $437,500 half each to the Sellers (the “Earn-out Payments”), payable as
follows:

 

		5.3.1.	$62,500
on the first anniversary of the Closing, 50% of which is subject to the Company’s annual revenue for the immediately preceding
year being a least $2,250,000, and 50% of which is subject to the Company’s profits for such period being at least $500,000,
and such payment will be prorated if either target is missed;

		 	 

		5.3.2.	$125,000
on the second anniversary of the Closing, 50% of which is subject to the Company’s annual revenue for the immediately preceding
year being a least $2,250,000, and 50% of which is subject to the Company’s profits for such period being at least $500,000,
and such payment will be prorated if either target is missed; and

		 	 

		5.3.3.	$125,000
on the third anniversary of the Closing, 50% of which is subject to the Company’s annual revenue for the immediately preceding
year being a least $2,250,000, and 50% of which is subject to the Company’s profits for such period being at least $500,000,
and such payment will be prorated if either target is missed; and

		 	 

		5.3.4.	$125,000
on the fourth anniversary of the Closing, 50% of which is subject to the Company’s annual revenue for the immediately preceding
year being a least $2,250,000, and 50% of which is subject to the Company’s profits for such period being at least $500,000,
and such payment will be prorated if either target is missed.

		 	 

		5.4.	If
the accounts receivable of the Target on the Closing Date, as defined below, exceeds $25,000, Company shall pay to the Sellers
the amount of such excess in cash within thirty (30) days after Closing. If the accounts receivable of the Target on the Closing
Date is less than $25,000, the Initial Payment shall be reduced by the amount of such shortfall.

		 	 

		5.5	The
prepaid expenses of the Target on the Closing Date will be offset against the accounts receivable requirement of the Target, and
the Target will only be required to have accounts receivable of $25,000 less the amount of the prepaid expenses.

		 	 

		6.	Closing.

		 	 

		6.1.	The
closing of the transactions contemplated by this Agreement (the “Closing”) shall take place on or about April
1, 2020 at a time and place mutually agreed to by Company and Seller (the “Closing Date”).

		 	 

		6.2.	The
obligations of the parties to consummate the transactions contemplated by this Agreement shall be subject to the fulfillment or
waiver, at or prior to the Closing, of each of the following conditions:

		 	 

		6.2.1.	Execution
of this Agreement and any other related transaction documents, whether described herein or otherwise (collectively, the “Documents”)
by the parties.

		 	 

		6.2.2.	Each
of Company, Target, and Sellers shall have obtained all necessary consents, permits and approvals, both internal and external.

 

    Page 3

     

    

 

		6.2.3.	Target
has provided to Company audited financial statements for the two fiscal years prior to the Closing Date.

		 	 

		6.2.3.1. 	Should
Sellers and/or Target decide not to complete the transactions contemplated in this Agreement, the Sellers and/or Target shall
pay to Parent a fee of $10,000 representing the partial cost of such audited financial statements.

		 	 

		6.2.4.	Company
shall have entered into a consulting agreement with each of the Sellers substantially in the form attached hereto as Exhibits
6.2.4(a) and 6.2.4(b).

		 	 

		6.2.5.	Company
shall have entered into a lease extension for a minimum of three years for the current office of Target upon similar terms and
conditions as the existing lease.

		 	 

		7.	Conduct
                                         of Business.

		 	 

		7.1.	From
the Effective Date until the Closing:

		 	 

		7.1.1.	Sellers
shall not dispose of, encumber, or otherwise transfer the Interests or any equity interests in any of the Target’s subsidiaries;

		 	 

		7.1.2.	Target
and AHP shall operate the business in accordance with past practices;

		 	 

		7.1.3.	Target
and AHP shall maintain their respective books, records, and financials in accordance with generally accepted accounting principles;

		 	 

		7.1.4.	Neither
Target nor AHP shall not enter into any transactions outside of the ordinary course of business without the prior written consent
of the Company;

		 	 

		7.1.5.	Target
and AHP shall take all steps necessary to preserve its assets and the goodwill and relationships with its partners, patients,
customers, suppliers, and employees;

		 	 

		7.1.6.	Target
                                         and AHP shall provide Company and its accountants, legal counsel, and other advisors,
                                         representatives, and agents (collectively, the “Representatives”)
                                         reasonable access to the properties, books, records, intellectual property, contracts,
                                         and other documents and information concerning their respective business, finances, and
                                         assets with the exception of any information protected under the Health Insurance Portability
                                         and Accountability Act of 1996, 42 U.S.C. §§ 1320d-1329d-8, and the regulations
                                         promulgated thereunder, each as amended (collectively, “HIPAA”);

		 	 

		7.1.7.	Target
and AHP shall provide Company and its Representatives with reasonable access during normal business hours and upon reasonable
notice to their respective legal, financial, accounting, and other representatives who have knowledge of their businesses, finances,
and assets, provided, however, that (a) the Representatives shall not contact any employees or patients of the Target or AHP without
Target’s or AHP’s consent, as applicable, and (b) the Representatives shall not access any information protected under
HIPAA.

 

    Page 4

     

    

 

	8.	Confidentiality.

 

		8.1.	The
terms of this Agreement are confidential and shall not be disclosed by any party except to such party’s accountants, legal
counsel, and other advisors, representatives, and agents; provided, however, that Parent and/or Company may disclose the terms
of this Agreement as may be required by the Securities and Exchange Commission or any exchange on which its shares may be quoted
or listed.

 

	9.	Sellers’
    Representations and Warranties. The Sellers, jointly and severally, represent and warrant as follows:

 

		9.1.	Ownership
of Interests.

		 	 

		9.1.1.	The
Sellers are the sole legal, beneficial, and record owners of the Interests.

		 	 

		9.1.2.	The
Interests represent all of the issued and outstanding securities of the Target and there are no options, warrants, calls, conversion
rights, commitments, agreements, restrictions, equity-linked securities, or rights of any character to which Target is a party
or by which Target may be bound obligating Target to issue additional securities.

		 	 

		9.1.3.	The
Sellers have (A) good and valid title to the Interests, free and clear of all claims, encumbrances, community property rights,
security interests, or other liens, and (B) all voting rights with respect to the Interests.

 

		9.1.4.	The
Interests are validly issued, fully paid and non-assessable and free from all taxes, liens and charges with respect to the issue
thereof.

		 	 

		9.2.	Authority;
Binding Obligation. The Sellers have the full right, power and authority to enter into this Agreement and to consummate the
transactions contemplated herein. The Sellers have duly and validly executed and delivered this Agreement and the Documents. This
Agreement and the Documents constitute legal, valid, and binding obligations of the Sellers, enforceable against the Sellers in
accordance with their respective terms subject to bankruptcy, reorganization, insolvency and other similar laws affecting the
enforcement of creditors’ rights in general and to general principles of equity (regardless of whether considered in a proceeding
in equity or an action at law).

		 	 

		9.3.	Broker’s
Fees. Sellers have no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect
to the transactions contemplated by this Agreement.

		 	 

		9.4.	Compliance
with Laws. Target is and has been at all times in compliance with all applicable federal, state, local, and foreign statutes,
laws, ordinances, rules, judgments, orders, and regulations of any governmental entity applicable to its business and operations.
All permits, licenses, and regulatory approvals required to conduct the business of Target as currently conducted have been obtained,
are in full force and effect, and are being complied with.

    Page 5

     

    

 

		10.	Target’s
Representations and Warranties. Target represents and warrants as follows:

 

		10.1.	Financial
Statements. Target has provided to Company the latest unaudited financial statements of Target dated 12/31/2019 (the “Financial
Statements”). The Financial Statements have been prepared in accordance with GAAP, consistently applied, and present
fairly the financial condition and results of operations of Target as of the times and for the periods referred to therein, subject
to changes resulting from normal recurring year-end adjustments. Target does not have any liabilities other than liabilities which
are (i) adequately reflected or reserved against on the Financial Statements, (ii) incurred in the ordinary course of business,
or (iii) not, individually or in the aggregate, material in amount. Target will not have any liabilities at Closing except from
the work done that day before closing. Parties will prepare a closing reconciliation statement and if net liabilities do not exceed
$5,000 as of closing, there will be no final adjustment. If the final reconciliation exceeds $5,000 there will be a final closing
adjustment to the cash at closing for any amount that exceeds the $5,000 agreed upon liability range.

		 	 

		10.2.	Title
to Assets. Target owns, and has good and valid title to, all assets owned by Target as of the Closing Date, including all
assets reflected on the Financial Statements. All of said assets are owned free and clear of any encumbrances and Target has sufficient
title to or rights to use its properties and assets to conduct its businesses as currently conducted.

		 	 

		10.3.	Tax
Matters. Target has timely filed with the appropriate governmental entity all tax returns that are required to be filed by
it (taking into account any extensions of time to file that have been duly perfected), and all such tax returns are true, correct
and complete in all material respects. All taxes due and payable by Target (whether or not shown or required to be shown on any
tax return) have been timely and fully paid to the appropriate governmental entity or properly accrued. Target has not been the
subject of any audit or other examination of taxes by any governmental entity.

		 	 

		10.4.	Material
Contracts. Schedule 10.4 sets forth all contracts of the Target material to the operation of the business as conducted
on the Closing Date, copies of which have been previously provided to Company (the “Target Material Contracts”).
Target has not, in any material respect, violated or breached, or committed any default under, any Target Material Contract. Other
than the Target Material Contracts, Target is not a party to any contract which requires or is likely to require payment or consideration
in excess of $25,000 per year.

		 	 

		10.5.	Intellectual
Property. All issuances, registrations and applications pertaining to intellectual property rights and domain names owned
by or filed in the name of Target as of the Closing Date that are material to the conduct of the business as currently conducted
are set forth on Schedule 10.5 (collectively, “Target IP”). All Target IP is valid and enforceable and Target
has the right to use all Target IP free and clear of all liens.

		 	 

		10.6.	Target
Subsidiary. Target owns all of the issued and outstanding securities of AHP and there are no options, warrants, calls, conversion
rights, commitments, agreements, restrictions, equity-linked securities, or rights of any character to which AHP is a party or
by which AHP may be bound obligating AHP to issue additional securities.

 

    Page 6

     

    

 

		10.7.	Legal
Proceedings. As of the Closing Date, there is no material legal action, suit, arbitration, claim, investigation or proceeding
(whether federal, state, local or foreign) pending, at law or in equity, or before or by any governmental entity, or threatened
in writing against (a) Target or any of its properties, assets, or businesses, or (b) against any present or former officer, director
or employee of Target.

		 	 

		10.8.	Employees.
Target is, and at all times since its formation has been, (A) in compliance with all applicable laws and regulations respecting
wages and hours, including, without limitation, with respect to the proper classification of employees for purposes of federal,
state and local law, and the proper classification and treatment of any independent contractor who has provided or currently provides
service to the Target, and (B) in material compliance with all other applicable laws and regulations respecting labor, employment,
fair employment practices, work place safety and health and terms and conditions of employment as well as the Immigration Reform
Control Act of 1986 and has a copy of U.S. Citizenship and Immigration Services Form I-9 for each of its current employees.

		 	 

		10.9.	Cash
on Hand. On the Closing Date, Target shall have $50,000 cash in its bank account. An adjustment to the Initial Payment shall
be made for any variance therefrom.

		 	 

		10.10. 	Authority;
Binding Obligation. Target has the full right, power, and authority to enter into this Agreement and to consummate the transactions
contemplated herein. Target has duly and validly executed and delivered this Agreement and this Agreement constitutes a legal,
valid and binding obligation of Target, enforceable against Target in accordance with its terms subject to bankruptcy, reorganization,
insolvency, and other similar laws affecting the enforcement of creditors’ rights in general and to general principles of
equity (regardless of whether considered in a proceeding in equity or an action at law). The undersigned is a duly authorized
representative of Target and all necessary entity action has been taken to authorize the undersigned to enter into this Agreement
and to consummate the transactions contemplated herein.

		 	 

		10.11. 	Broker’s
Fees. Target has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to
the transactions contemplated by this Agreement.

		 	 

		11.	AHP’s
Representations and Warranties. AHP represents and warrants as follows:

		 	 

		11.1.	Title
to Assets. AHP owns, and has good and valid title to, all assets owned by AHP as of the Closing Date. All of said assets are
owned free and clear of any encumbrances and AHP has sufficient title to or rights to use its properties and assets to conduct
its businesses as currently conducted.

		 	 

		11.2.	Tax
Matters. AHP has timely filed with the appropriate governmental entity all tax returns that are required to be filed by it
(taking into account any extensions of time to file that have been duly perfected), and all such tax returns are true, correct
and complete in all material respects. All taxes due and payable by AHP (whether or not shown or required to be shown on any tax
return) have been timely and fully paid to the appropriate governmental entity or properly accrued. AHP has not been the subject
of any audit or other examination of taxes by any governmental entity.

 

    Page 7

     

    

 

		11.3.	Material
Contracts. Schedule 11.3 sets forth all contracts of the AHP material to the operation of the business as conducted on the
Closing Date, copies of which have been previously provided to Company (the “AHP Material Contracts”). AHP
has not, in any material respect, violated or breached, or committed any default under, any AHP Material Contract. Other than
the AHP Material Contracts, AHP is not a party to any contract which requires or is likely to require payment or consideration
in excess of $25,000 per year.

		 	 

		11.4.	Intellectual
Property. All issuances, registrations and applications pertaining to intellectual property rights and domain names owned
by or filed in the name of AHP as of the Closing Date that are material to the conduct of the business as currently conducted
are set forth on Schedule 11.4 (collectively, “AHP IP”). All AHP IP is valid and enforceable and AHP has the
right to use all AHP IP free and clear of all liens.

		 	 

		11.5.	Legal
Proceedings. As of the Closing Date, there is no material legal action, suit, arbitration, claim, investigation or proceeding
(whether federal, state, local or foreign) pending, at law or in equity, or before or by any governmental entity, or threatened
in writing against (a) AHP, or any of its properties, assets, or businesses, or (b) against any present or former officer, director
or employee of AHP.

		 	 

		11.6.	Authority;
Binding Obligation. AHP has the full right, power, and authority to enter into this Agreement and to consummate the transactions
contemplated herein. AHP has duly and validly executed and delivered this Agreement and this Agreement constitutes a legal, valid
and binding obligation of AHP, enforceable against AHP in accordance with its terms subject to bankruptcy, reorganization, insolvency,
and other similar laws affecting the enforcement of creditors’ rights in general and to general principles of equity (regardless
of whether considered in a proceeding in equity or an action at law). The undersigned is a duly authorized representative of AHP
and all necessary entity action has been taken to authorize the undersigned to enter into this Agreement and to consummate the
transactions contemplated herein.

		 	 

		11.7.	Broker’s
Fees. AHP has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to the
transactions contemplated by this Agreement.

		 	 

		11.8.	Employees.
AHP is, and at all times since its formation has been, (A) in compliance with all applicable laws and regulations respecting wages
and hours, including, without limitation, with respect to the proper classification of employees for purposes of federal, state
and local law, and the proper classification and treatment of any independent contractor who has provided or currently provides
service to AHP, and (B) in material compliance with all other applicable laws and regulations respecting labor, employment, fair
employment practices, work place safety and health and terms and conditions of employment as well as the Immigration Reform Control
Act of 1986 and has a copy of U.S. Citizenship and Immigration Services Form I-9 for each of its current employees.

 

    Page 8

     

    

 

	12.	Company’s
    Representations and Warranties. The Company represents and warrants as follows:

 

		12.1.	Authority;
Binding Obligation. The Company has the full right, power, and authority to enter into this Agreement and to consummate the
transactions contemplated herein. The Company has duly and validly executed and delivered this Agreement and this Agreement constitutes
a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms subject to
bankruptcy, reorganization, insolvency, and other similar laws affecting the enforcement of creditors’ rights in general
and to general principles of equity (regardless of whether considered in a proceeding in equity or an action at law). The undersigned
is a duly authorized representative of the Company and all necessary entity action has been taken to authorize the undersigned
to enter into this Agreement and to consummate the transactions contemplated herein.

		 	 

		12.2.	Broker’s
Fees. Company has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to
the transactions contemplated by this Agreement.

 

	13.	Health
    Care Matters.

 

		13.1.	Definitions.

		 	 

		13.1.1.	“Affiliate”
means (i) with respect to any Person that is not a natural person, any other Person controlling, controlled by or under common
control with such Person, where “control” means the possession, directly or indirectly, of the power to direct or
cause the direction of the management and policies of a Person whether through the ownership of voting securities, as trustee,
personal representative or executor, by contract, credit arrangement or otherwise, and, (ii) with respect to any Person who is
a natural person, a Family Member of such Person.

		 	 

		13.1.2.	“Health
Care Laws” means all applicable laws pertaining to the health care regulatory matters applicable to the operations of
the Target and ACO, including but not limited to: (i) the Medicare statute (Title XVIII of the Social Security Act, 42 U.S.C.
§ 1395 et seq.), the Medicaid statute (Title XIX of the Social Security Act, 42 U.S.C. § 1396 et seq.), including the
Medicare Part D program and the Medicare Advantage program, the federal TRICARE statute (10 U.S.C. § 1071 et seq.) and any
other federal, state or local governmental health care programs, including applicable program requirements; (ii) any applicable
criminal laws relating to health care, including all criminal false claims statutes (e.g., 18 U.S.C. Sections 287 and 1001); (iii)
the Civil Monetary Penalties Law (42 U.S.C. §§ 1320a-7a); (iv) all applicable laws relating to health care fraud and
abuse, including but not limited to the civil False Claims Act of 1863 (31 U.S.C. Section § 3729 et seq.), the federal Anti-Kickback
Statute (42 U.S.C. § 1320a-7b(b)); (v) the Physician Self-Referral Law (42 U.S.C. § 1395nn), all applicable federal
and state self-referral prohibitions, state anti-kickback and illegal remuneration laws; (vi) HIPAA, (vii) the Health Information
Technology for Economic and Clinical Health Act (42 U.S.C. § 3000 et seq.), (viii) state health information breach notification
laws, and (ix) the regulations promulgated under any of the laws set forth above.

 

    Page 9

     

    

 

		13.1.3.	“Person”
means any individual, partnership, limited liability company, corporation, cooperative, association, joint stock company, trust,
joint venture, unincorporated organization or governmental authority, body or entity or any department, agency or political subdivision
thereof.

		 	 

		13.2.	Target
and AHP, jointly and severally, represent and warrant as follows:

		 	 

		13.2.1.	Target,
AHP, and each of their respective Affiliates and any other Person who provides services under a contract with the Target, AHP,
or any of their respective Affiliates are, and have at all times been, operating in compliance in all material respects with applicable
federal, state and local laws, statutes, rules, regulations, ordinances, codes applicable to the Target and the AHP, including
but not limited to all Health Care Laws.

		 	 

		13.2.2.	Target,
AHP, and each of their respective Affiliates are and have been at all times operating in compliance in all material respects with
all terms of any data use agreement, participation agreement or any other agreement with the Center for Medicare and Medicaid
Services under the Medicare Shared Savings Program or any other governmental program.

		 	 

		13.2.3.	With
the exception of items identified on Schedule 13.2.3, neither Target, AHP, nor any of their respective Affiliates have entered
into any arrangements with any Person requiring a waiver of any Health Care Laws, and for any arrangements identified on Schedule
13.2.3, Target, AHP, and each of their respective Affiliates have satisfied all regulatory requirements for application of any
waiver.

		 	 

		13.2.4.	Neither
Target, AHP, any of their respective Affiliates, employees or contractors nor any Person who provided services to the Target,
AHP, or any of their respective Affiliates, has engaged in any activity which would be likely to lead to an investigation by the
Office of the Inspector General, any Medicare or Medicaid Fraud Control Unit, or other governmental authority or which would be
likely to lead to an action or proceeding under any applicable Health Care Law.

 

    Page 10

     

    

 

		13.2.5.	Target,
AHP, and each of their respective Affiliates has (i) filed all reports and billings required to be filed with respect to each
governmental or third party payor in compliance in all material respects with applicable laws applicable to such governmental
or third party payor program requirements, and (ii) paid all known and undisputed refunds, overpayments, discounts and adjustments
due with respect to any such report or billing. There are no pending or threatened audits, investigations, appeals, adjustments
or legal proceedings relating to such claims.

		 	 

		13.2.6.	No
event has occurred which would provide the basis for termination of any participating provider agreement or similar contract or
arrangement between Target, AHP, and any of their respective Affiliates and a governmental or third party payor.

 

	14.	Parent’s
    Representations and Warranties. The Parent represents and warrants as follows:

 

		14.1.	Authority;
Binding Obligation. Parent has the full right, power, and authority to enter into this Agreement and to consummate the transactions
contemplated herein. The Parent has duly and validly executed and delivered this Agreement and this Agreement constitutes a legal,
valid and binding obligation of the Parent, enforceable against the Parent in accordance with its terms subject to bankruptcy,
reorganization, insolvency, and other similar laws affecting the enforcement of creditors’ rights in general and to general
principles of equity (regardless of whether considered in a proceeding in equity or an action at law). The undersigned is a duly
authorized representative of the Parent and all necessary entity action has been taken to authorize the undersigned to enter into
this Agreement and to consummate the transactions contemplated herein.

		 	 

		14.2.	Broker’s
Fees. Parent has no liability or obligation to pay any fees or commissions to any broker, finder, or agent with respect to
the transactions contemplated by this Agreement.

 

	15.	Indemnification.
    Each of Target, AHP, and Sellers shall, jointly and severally, indemnify and hold harmless the Company, Parent, and their
    respective officers, managers, directors, employees, equityholders, members, agents, representatives, successors and permitted
    assigns (each, an “Indemnified Party”) from and against any losses that an Indemnified Party suffers, sustains
    or becomes subject to as a result of or in connection with any inaccuracy or breach of any representation or warranty made
    by the Target, AHP, or any Seller or any failure to perform or breach of any covenant or agreement of Target, AHP, or any
    Seller.

 

    Page 11

     

    

 

	16.	Notices.
    Any notices, consents, waivers or other communications required or permitted to be given under the terms hereof must be in
    writing and will be deemed to have been delivered: (i) upon receipt, when delivered personally; or (ii) three (3) business
    days after deposit with a recognized overnight delivery service, properly addressed to the party to receive the same, postage
    prepaid for overnight delivery. The addresses for such communications shall be:

 

	If
    to Company:	HLYK
    Florida, LLC
	 	ATTN:
    George O’Leary 

1035 Collier Center Way 

Suite 3
	 	Naples,
    FL 34110
	 	 
	With
    a copy to (which shall not constitute notice):  	K&L
    Gates LLP
	 	ATTN:
    Clayton Parker 

200 South Biscayne Blvd. 

Suite 3900
	 	Miami,
    FL 33131
	 	 
	If
    to Parent:	HealthLynked
    Corp.
	 	ATTN:
    George O’Leary
	 	1726
    Medical Blvd. 

Suite 101
	 	Naples,
    FL 34110
	 	 
	With
    a copy to (which shall not constitute notice): 	K&L
    Gates LLP
	 	ATTN:
    Clayton Parker 

200 South Biscayne Blvd. 

Suite 3900
	 	Miami,
    FL 33131
	 	 
	If
    to Sellers:	Nicole
    Bradberry
	 	 
	 	Marsha
    Boggess
	 	 
	If
    to Target:	Cura
    Health Management, LLC
	 	 
	If
    to AHP:	ACO
    Health Partners, LLC

 

    Page 12

     

    

 

	17.	Successors
    and Assigns; Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto, and their
    respective permitted assigns, heirs, administrators, executors or personal representatives.

 

	18.	Counterparts.
    This Agreement may be executed in any number of counterparts, including counterparts signed electronically, received as a
    signed confirmed fax, or via email or other electronic signature, including DocuSign, and by different parties hereto in separate
    counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute
    one and the same agreement.

 

	19.	Governing
    Law, Venue. This Agreement shall be governed by and interpreted in accordance with the laws of the State of Florida, without
    regard to conflict of law principles. Each party hereto irrevocably consents to the non-exclusive jurisdiction of the federal
    or state courts located in and for Collier County, Florida with respect to any action, suit or proceeding seeking to enforce
    any provision of, or based on any matter arising out of or in connection with, this Agreement or the transactions contemplated
    hereby, and each party hereto hereby unconditionally and irrevocably waives, to the fullest extent permitted by law, any objection
    which such party may now or hereafter have to the laying of venue in any such court or that any such suit, action or proceeding
    which is brought in any such court has been brought in an inconvenient forum.

 

	20.	Modifications
    and Waivers. No change, modification, or waiver of any provision of this Agreement shall be valid or binding unless it
    is in writing and signed by the parties intended to be bound. No waiver of any breach, term, or condition of this Agreement
    by either party shall constitute a subsequent waiver of the same or any other breach, term or condition or a continuing waiver
    after demand for strict compliance.

 

	21.	Further
    Assurances. The parties agree to execute and deliver all such other and additional instruments and documents and do all
    such other acts and things as may be reasonably requested by the other party to more fully effectuate this Agreement.

 

	22.	Costs.
    Each party shall be responsible for all of their respective costs and expenses in connection with the transactions contemplated
    in this Agreement.

 

	23.	Entire
    Agreement. The Documents, including any schedules, exhibits, or appendixes thereto which are hereby incorporated herein,
    constitute the entire agreement between the parties relating to the subject matter hereof and all previous agreements or arrangements
    between the parties, written or oral, relating to the subject matter hereof are superseded.

 

	24.	Severability.
    If any provision of this Agreement is held to be invalid or unenforceable, in whole or in part, by any court of competent
    jurisdiction, then the remaining provisions of this Agreement will remain in full force and effect.

 

SIGNATURE
PAGE FOLLOWS

 

    Page 13

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the Effective Date.

 

	COMPANY:	 	SELLERS:
	 	 	 	 
	HLYK
    FLORIDA, LLC	 	BRADBERRY
    HOLDINGS, LLC
	 	 	 	 
	By:	/s/
    George O’Leary	 	/s/
    Nicole Bradberry
	Name:	George
    O’Leary	 	Nicole
    Bradberry, CEO
	Title	Chief
    Financial Officer	 	 
	 	 	 	 
	 	 	 	FOCUSONE
    HOLDINGS, LLC
	 	 	 	 
	 	 	 	/s/
    Marsha Boggess
	 	 	 	Marsha
    Boggess, CEO

 

	PARENT:	 	TARGET:
	 	 	 	 	 
	HEALTHLYNKED
    CORP.	 	CURA
    HEALTH MANAGEMENT, LLC
	 	 	 	 	 
	By:	/s/
    George O’Leary	 	By:	/s/
    Nicole Bradberry
	Name: 	George
    O’Leary	 	Name: 	Nicole
    Bradberry
	Title	Chief
    Financial Officer	 	Title	Managing
    Partner   
	 	 	 	 	 
	 	 	 	By:	/s/ Marsha
Boggess
	 	 	 	Name:	Marsha
    Boggess
	 	 	 	Title	Member
    Manager
	 	 	 	 	 
	 	 	 	ACO
    HEALTH PARTNERS, LLC
	 	 	 	 	 
	 	 	 	By:	/s/ Nicole
    Bradberry
	 	 	 	Name:	Nicole
    Bradberry
	 	 	 	Title	ACO
    Executive
	 	 	 	 	 
	 	 	 	By:	/s/
    Marsha Boggess
	 	 	 	Name:	Marsha
    Boggess
	 	 	 	Title	Member
    Manager

 

Signature
Page to Agreement and Plan of MergerExhibit

Exhibit 10.1

PHILIP MORRIS INTERNATIONAL INC.
2017 PERFORMANCE INCENTIVE PLAN 

RESTRICTED STOCK UNIT AGREEMENT
FOR PHILIP MORRIS INTERNATIONAL INC. COMMON STOCK
 (February 6, 2020)

PHILIP MORRIS INTERNATIONAL INC. (the “Company”), a Virginia corporation, hereby grants to the employee identified in the Award Statement (the “Employee”) under the Philip Morris International Inc. 2017 Performance Incentive Plan (the “Plan”), a Restricted Stock Unit Award (the “Award”) dated February 6, 2020 (the “Award Date”) with respect to the number of shares of the Common Stock of the Company (the “Common Stock”) set forth in the Award Statement (the “RSUs”), all in accordance with and subject to the following terms and conditions:

1.    Normal Vesting.  Subject to Section 2 of this Agreement below, the RSUs shall become fully vested on the Vesting Date set forth in the Award Statement (the “Vesting Date”), provided that the Employee remains an employee of the PMI Group during the entire period commencing on the Award Date and ending on the Vesting Date, and provided further that the Employee has complied with all applicable provisions of HSR. 

2.    Termination of Employment Before Vesting Date.  (a) In the event of the termination of the Employee’s employment with the PMI Group prior to the Vesting Date due to (i) death, Disability or (ii) Normal Retirement, or (iii) early retirement or termination of employment (other than for cause), in either case by mutual agreement and after the Employee has attained age 58, then the RSUs shall become fully vested on the date of death, Disability, Normal Retirement, or such early retirement or termination of employment or the date specified in such mutual agreement. 

(b)    Subject to the provisions of section 6(a) of the Plan, if the Employee’s employment with the PMI Group is terminated prior to the Vesting Date in circumstances not specified in items (i), (ii) or (iii) of the preceding paragraph, the Employee shall forfeit all rights to the RSUs.  Notwithstanding the foregoing and except as provided in section 6(a) of the Plan, upon the termination of an Employee’s employment with the PMI Group, the Compensation Committee may, in its sole discretion, vest some or all of the RSUs.

(c)    If within the period of 12 months prior to the date of termination of employment, the Employee was an Executive Officer (as designated by the Board of Directors of the Company within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended) and the termination of employment of such Employee is due to a  reason other than death or Disability,  any shares of Common Stock that are received by such Employee as a result of accelerated vesting provisions of Section 2(a) or (b), shall be automatically subject to a holding period that expires 12 consecutive months from the date of termination of employment.

3.    Voting and Dividend Rights; Withholding Tax on Dividend Equivalents.  The Employee does not have the right to vote the RSUs or receive dividends prior to the date, if any, such RSUs are paid to the Employee in the form of Common Stock pursuant to the terms hereof.  However, unless otherwise determined by the Compensation Committee, the Employee shall receive cash amounts (less applicable withholding taxes) equal to the dividends paid from the date the Award is granted through the date of payment under Section 7 of this Agreement

with respect to shares of Common Stock issuable with respect to the Award, as such dividends are paid.
4.    Transfer Restrictions.  This Award and the RSUs are non-transferable and may not be transferred, assigned, hypothecated, pledged or otherwise encumbered and shall not be subject to execution, attachment or similar process.  Upon any attempt to effect any such disposition, or upon the levy of any such process, the Award shall immediately become null and void and the RSUs shall be forfeited.  These restrictions shall not apply, however, to any payments received pursuant to Section 7 of this Agreement below. In addition, shares of Common Stock subject to the holding period described in Section 2 (c) of this Agreement may not be transferred, assigned, hypothecated, pledged or otherwise encumbered for the duration of the applicable holding period.
5.    Withholding Taxes on Common Stock upon Vesting.  With respect to Common Stock issuable upon vesting, the Company is authorized to satisfy the actual statutory withholding taxes, or hypothetical withholding tax amounts if applicable, arising from this Award by (a) deducting the number of shares of Common Stock payable under the RSUs having an aggregate value equal to the amount of withholding taxes due from the total number of shares of Common Stock payable under the RSUs becoming subject to current taxation or (b) the remittance of the required amounts from any proceeds realized upon the open-market sale of the Common Stock received in payment of vested RSUs by the Employee.  Shares of Common Stock payable under the RSUs deducted from this Award in satisfaction of tax withholding shall be valued at the Fair Market Value of the Common Stock on the date as of which the amount giving rise to the withholding requirement first became includible in the gross income of the Employee under applicable tax laws. If the Employee is on an international assignment, the Company will calculate the amount of hypothetical tax which will be imposed on the Employee’s RSUs, in accordance with the Company’s guidelines in force at the time the withholding obligation arises.
6.    Death of Employee.  If any of the RSUs shall vest upon the death of the Employee, any Common Stock received in payment of the vested RSUs shall be registered in the name of the estate of the Employee.
7.      Settlement of RSUs.  Each RSU granted pursuant to this Award represents an unfunded and unsecured promise of the Company, subject to the vesting and other terms of this Agreement, to issue to the Employee one share of the Common Stock.  Except as otherwise expressly provided in the Award Statement and subject to the terms of this Agreement, such issuance shall be made to the Employee (or, in the event of his or her death to the Employee’s estate as provided above) as soon as reasonably practicable following the vesting of the RSU pursuant to Section 1 or 2 of this Agreement (and, if the Employee is subject to US Federal income tax, in no event later than March 15 of the calendar year following such Employee’s separation from service, except as otherwise provided in Section 8 below), provided, however, that if the Company determines that settlement in the form of Common Stock is impractical or impermissible under the laws of the Employee’s country of residence, the RSUs will be settled in the form of cash, and provided further that any applicable waiting period under HSR has expired or been terminated.
8.    Special Payment Provisions.  Notwithstanding anything in this Agreement to the contrary, if the Employee is subject to US Federal income tax on any part of the payment of the RSUs, and will become eligible for Normal Retirement (a) for RSUs with a Vesting Date between January 1 and March 15, before the calendar year preceding the Vesting Date and (b) for RSUs with a Vesting Date after March 15, before the calendar year in which such Vesting 

Date occurs, then the RSUs shall be subject to the following provisions of this Section 8.  If the Employee is a “specified employee” within the meaning of Code section 409A, any payment of RSUs under Section 7 of this Agreement above that is on account of his separation from service and is scheduled to be paid within six months after such separation from service shall accrue without interest and shall be paid as soon as reasonably practicable after the first day of the seventh month, or thirteenth month in situations described in Section 2(c) of this Agreement if applicable, beginning after the date of the Employee’s separation from service or, if earlier, as soon as reasonably practicable following the Employee’s death. During such delayed distribution period, the Employee shall continue to receive cash amounts equal to dividends on Common Stock pursuant to Section 3 of this Agreement, and such amounts shall be paid to the Employee as such dividends are paid.  In the event of a “Change in Control” under section 6(b) of the Plan that is not also a “change in control event” with the meaning of Treas. Reg. §1.409A-3(i)(5)(i), the RSUs shall vest as set forth in section 6(a) of the Plan, but shall not be paid upon such Change in Control as provided by section 6(a) of the Plan, and shall instead be paid at the time the RSUs would otherwise be paid pursuant to this Agreement.  References to termination of employment and separation from service shall be interpreted to mean a separation from service, within the meaning of Code section 409A, with the Company and all of its affiliates treated as a single employer under Code section 409A.  This Agreement shall be construed in a manner consistent with Code section 409A.
9.    Board Authorization in the Event of Restatement.  Notwithstanding anything in this Agreement to the contrary, if the Board of Directors of the Company or an appropriate Committee of the Board determines that, as a result of fraud, misconduct, a restatement of the Company’s financial statements, or a significant write-off not in the ordinary course affecting the Company’s financial statements, an Employee has received more compensation in connection with this Award than would have been paid absent the fraud, misconduct, write-off or incorrect financial statement, the Board or Committee, in its discretion, shall take such action with respect to this Award as it deems necessary or appropriate to address the events that gave rise to the fraud, misconduct, write-off or restatement and to prevent its recurrence.  Such action may include, to the extent permitted by applicable law, causing the partial or full cancellation of this Award and, with respect to RSUs that have vested, requiring the Employee to repay to the Company the partial or full Fair Market Value of the Award determined at the time of vesting.  The Employee agrees by accepting this Award that the Board or Committee may make such a cancellation, impose such a repayment obligation, or take other necessary or appropriate action in such circumstances.
10.    Other Terms and Definitions.  The terms and provisions of the Plan (a copy of which will be furnished to the Employee upon written request to the Office of the Secretary, Philip Morris International Inc., 120 Park Avenue, New York, New York 10017) are incorporated herein by reference.  To the extent any provision of this Award is inconsistent or in conflict with any term or provision of the Plan, the Plan shall govern. Capitalized terms not otherwise defined herein have the meaning set forth in the Plan.
For purposes of this Agreement, (a) the term “Disability” means permanent and total disability as determined under procedures established by the Company for purposes of the Plan, and (b) the term “Normal Retirement” means retirement from active employment under a pension plan of any member of the PMI Group or under an employment contract with any member of the PMI Group on or after the date specified as the normal retirement age in the pension plan or employment contract, if any, under which the Employee is at that time accruing pension benefits for his or her current service (or, in the absence of a specified  normal retirement age, the age at which pension benefits under such plan or contract become payable without reduction for early commencement and without any requirement of a particular period

of prior service).  In any case in which (i) the meaning of “Normal Retirement” is uncertain under the definition contained in the prior sentence or (ii) a termination of employment at or after age 65 would not otherwise constitute “Normal Retirement,” an Employee’s termination of employment shall be treated as a “Normal Retirement” under such circumstances as the Compensation Committee, in its sole discretion, deems equivalent to retirement.  “PMI Group” means the Company and each of its subsidiaries and affiliates.  Generally, for purposes of this Agreement, (x) a “subsidiary” includes only any company in which the Company, directly or indirectly, has a beneficial ownership interest of greater than 50 percent and (y) an “affiliate” includes only any company that (A) has a beneficial ownership interest, directly or indirectly, in the Company of greater than 50 percent or (B) is under common control with the Company through a parent company that, directly or indirectly, has a beneficial ownership interest of greater than 50 percent in both the Company and the affiliate.  “Compensation Committee” means the Compensation and Leadership Development Committee of the Board of Directors of the Company.  “HSR” means the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended.  “Code section 409A” means section 409A of the Internal Revenue Code and the regulations thereunder.

IN WITNESS WHEREOF, this Restricted Stock Unit Agreement has been duly executed as of February 6, 2020.

PHILIP MORRIS INTERNATIONAL INC.
	
		
	

	/s/ JERRY WHITSON

Jerry Whitson
Deputy General Counsel and Corporate Secretary
Philip Morris International Inc.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00304-of-00352.parquet"}]]